Trials / Unknown
UnknownNCT04474951
Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies
Food Supplements to Control Signs and Symptoms Induced by Cancer Therapies
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the impact of food supplements (herbal remedies) on sign and symptoms induced by cancer therapies: Nettle will be administered for improvement of anemia and fatigue; Peppermint will be administered for improvement of nausea. Secondary aims of the trial are to evaluate the impact of these supplements on the quality of life and to evaluate their tolerability profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Stinging Nettle | Eligible patients will take 40 drops TID of Fluid Extract of Stinging Nettle for control of anemia. |
| DIETARY_SUPPLEMENT | Stinging Nettle | Eligible patients will take 40 drops TID of Fluid Extract of Stinging Nettle for control of fatigue. |
| DIETARY_SUPPLEMENT | Peppermint | Eligible patients will take 40 drops TID of Fluid Extract of Peppermint for control of nausea. |
Timeline
- Start date
- 2019-06-20
- Primary completion
- 2021-03-01
- Completion
- 2021-09-01
- First posted
- 2020-07-17
- Last updated
- 2020-07-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04474951. Inclusion in this directory is not an endorsement.